The Division of Pediatric Endocrinology & Diabetes
The work of this division successfully combines the worlds of investigation, innovation, and clinical care to improve the diagnosis and treatment of endocrine disorders.
Wild for our Fellows!
Fellows Retreat during Fellows Appreciation week. They successfully completed the escapre room.
The DirecNet Group is recognized with the ADA Presidential Abstract Award at the 79th Scientific Session in San Francisco.
Stanford DirecNet Team Members L to R: Ryan Kingman, Bruce Buckingham, Tandy Aye, and Darrell Wilson
David Scheinker, PhD joins the Division of Pediatric Endocrinology and Diabetes
Concurrently with his appointment to Pediatric Endocrinology, David Scheinker is an Adjunct Professor in the Department of Management Science and Engineering and The Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. His appointments in the School of Medicine, School of Engineering, and the Children's Hospital are designed to facilitate collaboration between the three institutions. To foster such collaboration he founded and directs SURF Stanford Medicine, a group that brings together students and faculty from the Schools of Medicine and Engineering with nurses and administrators from the Children's Hospital to improve the quality and reduce the cost of care using operations research methodology. SURF is currently working with other faculty in Pediatric Endocrinology to develop tools to detect and predict deteriorating glucose control and develop personalized care responses for Type 1 Diabetes using continuous glucose monitor data. David also serves on the faculty of Stanford's Clinical Excellence Research Center where he works on transforming SURF's hospital projects into broader interventions that have the potential to reduce the nationwide cost of high quality care.
Is the Surgical World Ready for Adolescent Gender Surgery? | Tandy Aye, MD | TEDXUniversityofNevada
TEDx link: https://youtu.be/L240CPOJ6FM
Dr. Eric Appel now has a ‘courtesy appointment’ in the division
The Appel lab develops new technologies to enable next-generation biopharmaceutical formulations. Dr Appel has a strong interest in engineering new insulin formulations that can address long-standing challenges with current formulations to enhance the management of diabetes. Dr Appel’s research is funded by an R01 from the NIDDK, a Junior Faculty Development Award from the American Diabetes Association, and a Stanford Diabetes Research Center Pilot & Feasibility award funded by the Maternal Child Health Research Institute. Dr Appel’s research on insulin formulations complements the clinical research in the division on diabetes technology including work on the artificial pancreas.Dr Appel serves as a basic science advisor for fellows and faculty in the area of insulin formulations and an educational resource for trainees and faculty for the science of insulin and other hormonal therapies that are essential to clinical practice in pediatric endocrinology. More information can be found at www.supramolecularbiomaterials.com.
Employee of the Month!
Congratulations to Ofelia Colin, Administrative Associate in Pediatric Endocrinology, for receiving the Employee of the Month Award. Ofelia has worked in the Department for 15 years!
Congratulations to Ananta Addala, DO, MPH, Fellow in Pediatric Endocrinology, for being awarded as one of the winners of the current cycle of Rising Star Awards. The purpose of this small grant award is to support and encourage research efforts to fellows. The PES will fund a maximum of five grants every six months.
Feature: Stanford Diabetes Research Center
Learn more about the Diabetes Research Center and its work! David Maahs, MD, PhD, Association Director of the Stanford Diabetes Research Center; Division Chief and Professor of Pediatrics (Endocrinology), is featured in a Stanford Diabetes Clinic video.
Watch the video here. Dr. Maahs' research focuses on improving care and preventing complications in people with type 1 diabetes (T1D).
It's a Match! - Holly Cooper & Walter Zegarra to Join Fellowship Program
We are thrilled to announce that on December 13, our fellowship training program matched two out of two positions. We look forward to welcoming Holly Cooper, MD from UCLA and Walter Zegarra, MD from University of Miami to our team beginning July 7th, 2018.
Division Founder's Legacy Honored
50 Years Ago in The Journal of Pediatrics is a brief reflection on the prolific and ground-breaking work of Raymond Hintz, MD, founder of the Division of Pediatric Endocrinology at Stanford School of Medicine and author of over 350 publications.
Maria Chang, MD (fellow), Darrell Wilson, MD (faculty), and David Maahs, MD, PhD (chief) recall Hintz' first publication, Familial Holoprosencephaly with Endocrine Dysgenesis (1968), in a December 26, 2017 Journal of Pediatrics column. Read more about Hintz at Stanford Medicine Scope.
We're Open! - New Packard Children's Hospital
Lucile Packard Children’s Hospital Stanford has created one of America’s most technologically advanced, family-friendly and environmentally sustainable hospitals for babies, children and pregnant women. The new hospital, opened its doors to patients on December 9, 2017 adding 521,000 square feet of building space and 149 patient beds to its facility.
The patient rooms are now private and feature a bathroom with shower, fold-out bed and privacy curtains so families have the option to stay in-room with their child. Computer workspace, child broadcast center, playground, kitchen and laundry help support families during their stay.
Animas shutting down US operations for insulin pumps
On October 5, 2017, Johnson and Johnson and Animas pump company have confirmed they will shut down U.S. operations, and exit the insulin pump market. They have selected Medtronic as their partner-of-choice, and are offering their patients to switch to Medtronic insulin pumps. Current Animas users can continue using their current pump, and will be able to get their Animas pump supplies (reservoirs and infusion sets) from the vendor.
New FIASP insulin approved for adults
On September 29, 2017, the FDA approved the new Novo Nordisk FIASP insulin for adults. This is a faster acting meal time insulin, that can be used instead of Humalog or Novolog. Check with your insurance company to determine whether or not this is a product on your formulary.
Freestyle Libre Flash CGM approved for adults
On September 27, 2017, the FDA approved the Freesyle Libre Flash Continuous Glucose Monitor (CGM) system in adults 18 years old and up. The sensor is factory calibrated, meaning it does not require any fingerstick calibrations. The sensor can be worn for up to 10 days, after a 12 hour warm up phase.
This multidisciplinary clinic provides medical services for gender nonconforming youths and their families in one central location. The expert members of the Gender Clinic team consists of providers from pediatric endocrinology, adolescent medicine, pediatric urology and social services, supporting each child’s or adolescent’s gender identity. All our providers are members of the World Professional Association for Transgender Health (WPATH).
At Stanford Children’s Health, we bring experts in endocrinology, orthopedics, adolescent medicine, genetics and nephrology together to provide the best possible treatments for primary and secondary osteoporosis.
The pediatric endocrine bone health team at Stanford Children’s Health is nationally ranked in Diabetes & Endocrinology by U.S. News & World Report and treats children with endocrine disorders at our Welch Road clinic.
The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Join our mailing list
Subscribe to the pediatric endocrinology mailing list and receive emails regarding diabetes and the pediatric diabetes program here at Stanford.